When talking about blood cancer, traditional approaches such as chemotherapy and radiation often come with severe side effects, while sometimes failing to fully eradicate the disease. This leaves patients and their families frustrated, fearing that a relapse or lack of response could be inevitable. The emotional and physical toll is overwhelming, especially when there seems to be no clear path forward.

CAR T-cell therapy, however, is revolutionising how we approach these cancers. By reprogramming a patient's own immune cells to target and destroy cancer cells specifically, this cutting-edge treatment offers new hope to those who have exhausted other options. The therapy not only increases the chances of remission but also provides a more personalised, less invasive treatment compared to traditional methods.

Let's understand more about it in detail.

What is CAR T-cell Therapy?
What Conditions Can CAR T-cell Therapy Treat?
How Does CAR T-cell Therapy Work?
Did You Know?
Myths and Facts About Car T-cell Therapy
Conclusion
Whom to Consult
FAQs About CAR T-Cell Therapy

What is CAR T-cell Therapy?

CAR T-cell therapy stands for Chimeric Antigen Receptor T-cell therapy, which is a type of immunotherapy that utilises genetically engineered T-cells to attack cancer cells in the body.

What Conditions Can CAR T-cell Therapy Treat?

This therapy has shown promising results in treating certain types of cancer. CAR T-cell therapy has been mainly used to treat haematologic malignancies, particularly:

Acute lymphoblastic Leukaemia (ALL)
Diffuse large B-cell lymphoma (DLBCL)
Multiple myeloma
Mantle cell lymphoma
Chronic lymphocytic leukaemia (CLL)

CAR T-cell Therapy Work

How Does CAR T-cell Therapy Work?

CAR T-cell therapy is a form of immunotherapy that harnesses the power of a patient's own immune system to fight cancer. Here's an overview of how CAR T-cell therapy works:

Collection of T cells: A patient's own T cells (a type of immune cell) are extracted from their blood through a process called leukapheresis.
Genetic engineering: The collected T cells are genetically modified in a laboratory to express chimeric antigen receptors (CARs) on their surface. These receptors are designed to recognise specific proteins, known as antigens, that are present on cancer cells.
Multiplication: The engineered CAR T cells are then multiplied in the laboratory to create a larger population of these modified cells.
Infusion: The expanded CAR T cells are infused back into the patient's bloodstream. Once inside the body, these engineered cells target and bind to the cancer cells expressing the specific antigen recognised by the CAR.
Cell killing: Upon binding to the cancer cells, the CAR T cells become activated and initiate a cascade of immune responses, ultimately leading to the destruction of the cancer cells.
Persistence and memory: Some of the CAR T cells can persist in the body for an extended period, providing ongoing surveillance against cancer recurrence. Additionally, memory CAR T cells are generated to mount a rapid response if the cancer reappears.

Did You Know?

CAR T-cell therapy harnesses the power of a patient’s own immune system to target and destroy cancer cells.
Unlike traditional treatments, CAR T-cell therapy is a one-time infusion that can provide long-lasting remission for certain blood cancer patients.

Myths and Facts About Car T-cell Therapy

Myth 1: CAR T-cell therapy works for all types of cancers.
Fact: CAR T-cell therapy is currently approved for certain blood cancers, such as leukaemia and lymphoma. It is not yet widely used for solid tumours, although research is ongoing.

Myth 2: CAR T-cell therapy has severe side effects for everyone.
Fact: While some patients experience side effects like cytokine release syndrome, many others tolerate the treatment well, and doctors closely monitor patients to manage potential reactions.

Myth 3: CAR T-cell therapy guarantees a permanent cure.
Fact: CAR T-cell therapy has shown remarkable results, including long-term remission in many cases, but it doesn't guarantee a cure for all patients.

Conclusion

CAR T-cell therapy marks a groundbreaking advancement in the fight against blood cancers. Its ability to precisely target cancer cells, deliver long-lasting effects, and provide hope to patients with relapsed or treatment-resistant cancers sets it apart from traditional therapies. While challenges remain, including side effects and cost, ongoing research promises to refine and expand the use of CAR T-cell therapy and offer a brighter future for cancer patients.

Whom to Consult

If you're considering CAR T-cell therapy for cancer treatment, schedule a consultation with the specialists at Narayana Health. Our team will guide you through the process, explain the benefits and risks, and provide personalised care tailored to your needs.

Don’t Delay--- Call us @ 08068617735

References

https://my.clevelandclinic.org/health/treatments/17726-car-t-cell-therapy
https://www.cancer.gov/news-events/cancer-currents-blog/2023/universal-car-t-cell-blood-cancer